Europe Home Infusion Therapy Market size was valued at USD 14.2 billion in 2025 and is forecast to grow from USD 15.3 billion in 2026 to reach USD 23.3 billion by 2031, at a CAGR of 10.4%.
The Europe Home Infusion Therapy Market size was valued at USD 14.2 billion in 2025 and is forecast to grow from USD 15.3 billion in 2026 to reach USD 23.3 billion by 2031, at a CAGR of 10.4%. Home infusion therapy encompasses anti-infective therapy, enteral and parenteral nutrition, chemotherapy, and biologics administered intravenously or subcutaneously in patient homes or ambulatory settings, ranging from nurse-supervised IV infusion services to patient self-administration of subcutaneous therapies. The market sits at the intersection of home healthcare, specialty pharmacy, and chronic disease management, making it one of the most rapidly expanding care delivery categories across the regional healthcare services value chain.
Demand for home infusion therapy services remains anchored by rising chronic disease prevalence, growing patient preference for hospital-avoidance care models, and expanding payer support for cost-effective home-based infusion delivery across Germany, France, the United Kingdom, and Italy. Beyond anti-infective therapy, home infusion continues to enable applications in oncology supportive care, nutritional support, and biologic administration that require accurate, accessible infusion solutions. Increasing reimbursement coverage, expanding specialty pharmacy networks, and continued digital health monitoring integration are sustaining consumption even as the region transitions toward more patient-centric, tech-enabled home care delivery models.
Product Overview
Market Definition
Scope of the Market
Markets Covered
Years Considered for Study
Key Market Segmentations
Research Methodology
Objective of the Study
Baseline Methodology
Key Industry Partners
Major Association and Secondary Sources
Forecasting Methodology
Data Triangulation & Validation
Assumptions and Limitations
Executive Summary
Overview of the Market
Overview of Key Market Segmentations
Overview of Key Market Players
Overview of Key Regions/Countries
Overview of Market Drivers, Challenges, Trends
Voice of Customer
Europe Home Infusion Therapy Market Outlook
Market Size & Forecast
By Value
Market Share & Forecast
By Therapy Type (Anti-Infective Therapy, Enteral Nutrition, Parenteral Nutrition, Chemotherapy, Others)
By Application (Oncology, Infectious Diseases, Gastrointestinal Disorders, Cardiovascular Diseases, Others)
By End User (Home Care Settings, Hospitals & Clinics, Diagnostic Laboratories, Others)
By Country
By Company (2025)
Product Map
Germany Home Infusion Therapy Market Outlook
Market Size & Forecast
By Value
Market Share & Forecast
By Therapy Type
By Application
By End User
France Home Infusion Therapy Market Outlook
Market Size & Forecast
By Value
Market Share & Forecast
By Therapy Type
By Application
By End User
United Kingdom Home Infusion Therapy Market Outlook
Market Size & Forecast
By Value
Market Share & Forecast
By Therapy Type
By Application
By End User
Italy Home Infusion Therapy Market Outlook
Market Size & Forecast
By Value
Market Share & Forecast
By Therapy Type
By Application
By End User
Spain Home Infusion Therapy Market Outlook
Market Size & Forecast
By Value
Market Share & Forecast
By Therapy Type
By Application
By End User
Market Dynamics
Drivers
Challenges
Market Trends & Developments
Merger & Acquisition (If Any)
Product Launches (If Any)
Recent Developments
Europe Home Infusion Therapy Market: SWOT Analysis
Porter's Five Forces Analysis
Competition in the Industry
Potential of New Entrants
Power of Suppliers
Power of Customers
Threat of Substitute Products
Competitive Landscape
Fresenius SE & Co. KGaA
Business Overview
Products & Services
Recent Developments
Key Personnel
SWOT Analysis
Baxter International Inc.
B. Braun Melsungen AG
Coram LLC
Option Care Health Inc.
PharMerica Corporation
LinCare Holdings Inc.
AmerisourceBergen Corporation
Alcura plc
VitaLink Health Inc.
Strategic Recommendations
About Us & Disclaimer